{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:13:42Z","timestamp":1792098822277,"version":"4.4.0"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1093\/ndt\/gfs584","type":"journal-article","created":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T01:44:45Z","timestamp":1358991885000},"page":"1733-1743","source":"Crossref","is-referenced-by-count":46,"title":["A hepcidin lowering agent mobilizes iron for incorporation into red blood cells in an adenine-induced kidney disease model of anemia in rats"],"prefix":"10.1093","volume":"28","author":[{"given":"Chia Chi","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Vaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanzhuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Theurl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Stepanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane E.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria D.","family":"Cappellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guenter","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles C.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert Y.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodie L.","family":"Babitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,1,22]]},"reference":[{"key":"key\n\t\t\t\t20170518091637_GFS584C1","first-page":"279","article-title":"KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group","year":"2012","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170518091637_GFS584C2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrneph.2010.139","article-title":"Iron supplementation to treat anemia in patients with chronic kidney disease","volume":"6","author":"Besarab","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"key\n\t\t\t\t20170518091637_GFS584C3","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of anemia with epoetin alfa in chronic kidney disease","volume":"355","author":"Singh","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170518091637_GFS584C4","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170518091637_GFS584C5","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199808273390903","article-title":"The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin","volume":"339","author":"Besarab","year":"1998","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170518091637_GFS584C6","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/ki.2008.295","article-title":"Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes","volume":"74","author":"Szczech","year":"2008","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170518091637_GFS584C7","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1056\/NEJMoa1005109","article-title":"Erythropoietic response and outcomes in kidney disease and type 2 diabetes","volume":"363","author":"Solomon","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170518091637_GFS584C8","doi-asserted-by":"crossref","first-page":"710","DOI":"10.7326\/0003-4819-87-6-710","article-title":"Iron balance in hemodialysis patients","volume":"87","author":"Eschbach","year":"1977","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20170518091637_GFS584C9","first-page":"21","article-title":"Iron deficiency in patients with dialysis-associated anemia during erythropoietin replacement therapy: strategies for assessment and management","volume":"9","author":"Van Wyck","year":"1989","journal-title":"Semin Nephrol"},{"key":"key\n\t\t\t\t20170518091637_GFS584C10","first-page":"34","article-title":"An evaluation of the effectiveness of oral iron therapy in hemodialysis patients receiving recombinant human erythropoietin","volume":"48","author":"Markowitz","year":"1997","journal-title":"Clin Nephrol"},{"key":"key\n\t\t\t\t20170518091637_GFS584C11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0272-6386(95)90151-5","article-title":"Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation","volume":"26","author":"Fishbane","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170518091637_GFS584C12","first-page":"2070","article-title":"Importance of iron supply for erythropoietin therapy","volume":"10","author":"Sunder-Plassmann","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170518091637_GFS584C13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.5414\/CNP60335","article-title":"Targeting higher ferritin concentrations with intravenous iron dextran lowers erythropoietin requirement in hemodialysis patients","volume":"60","author":"DeVita","year":"2003","journal-title":"Clin Nephrol"},{"key":"key\n\t\t\t\t20170518091637_GFS584C14","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1681\/ASN.2006091034","article-title":"Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the dialysis patients\u2019 response to IV iron with elevated ferritin (DRIVE) study","volume":"18","author":"Coyne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518091637_GFS584C15","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1681\/ASN.2007050606","article-title":"Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin","volume":"19","author":"Kapoian","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518091637_GFS584C16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/ndt\/gfi087","article-title":"Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients","volume":"21","author":"Mircescu","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170518091637_GFS584C17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0272-6386(96)90546-6","article-title":"Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis","volume":"27","author":"Silverberg","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170518091637_GFS584C18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.5414\/CNP57136","article-title":"Reduction in erythropoietin doses by the use of chronic intravenous iron supplementation in iron-replete hemodialysis patients","volume":"57","author":"Chang","year":"2002","journal-title":"Clin Nephrol"},{"key":"key\n\t\t\t\t20170518091637_GFS584C19","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1038\/ki.1996.487","article-title":"A randomized controlled study of iron supplementation in patients treated with erythropoietin","volume":"50","author":"Macdougall","year":"1996","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170518091637_GFS584C20","first-page":"319","article-title":"Hematologic and erythropoietin responses to iron dextran in the hemodialysis environment","volume":"23","author":"Senger","year":"1996","journal-title":"ANNA J"},{"key":"key\n\t\t\t\t20170518091637_GFS584C21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0272-6386(99)70103-4","article-title":"A study of parenteral iron regimens in hemodialysis patients","volume":"34","author":"Besarab","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170518091637_GFS584C22","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000169008","article-title":"Effectiveness of intravenous administration of Fe-gluconate-Na complex to maintain adequate body iron stores in hemodialysis patients","volume":"16","author":"Navarro","year":"1996","journal-title":"Am J Nephrol"},{"key":"key\n\t\t\t\t20170518091637_GFS584C23","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease","volume":"352","author":"Weiss","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170518091637_GFS584C24","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3949\/ccjm.78a.10156","article-title":"Q: Is iron therapy for anemia harmful in the setting of infection?","volume":"78","author":"Daoud","year":"2011","journal-title":"Cleve Clin J Med"},{"key":"key\n\t\t\t\t20170518091637_GFS584C25","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1681\/ASN.2005080804","article-title":"Intravenous iron: how much is too much?","volume":"16","author":"Drueke","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518091637_GFS584C26","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.ajkd.2009.12.030","article-title":"Molecular Mechanisms of Hepcidin Regulation: Implications for the Anemia of CKD","volume":"55","author":"Babitt","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170518091637_GFS584C27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1525-139X.2008.00532.x","article-title":"The role of hepcidin in iron homeostasis and anemia in hemodialysis patients","volume":"22","author":"Eleftheriadis","year":"2009","journal-title":"Semin Dial"},{"key":"key\n\t\t\t\t20170518091637_GFS584C28","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"key":"key\n\t\t\t\t20170518091637_GFS584C29","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1182\/blood-2008-02-139915","article-title":"Immunoassay for human serum hepcidin","volume":"112","author":"Ganz","year":"2008","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170518091637_GFS584C30","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/ki.2009.21","article-title":"Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease","volume":"75","author":"Ashby","year":"2009","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170518091637_GFS584C31","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2215\/CJN.05931108","article-title":"Hepcidin\u2014a potential novel biomarker for iron status in chronic kidney disease","volume":"4","author":"Zaritsky","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518091637_GFS584C32","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ng.335","article-title":"BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism","volume":"41","author":"Andriopoulos","year":"2009","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20170518091637_GFS584C33","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ng.320","article-title":"Lack of the bone morphogenetic protein BMP6 induces massive iron overload","volume":"41","author":"Meynard","year":"2009","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20170518091637_GFS584C34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cmet.2005.10.010","article-title":"A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression","volume":"2","author":"Wang","year":"2005","journal-title":"Cell Metab"},{"key":"key\n\t\t\t\t20170518091637_GFS584C35","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1182\/blood-2011-03-339952","article-title":"Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in mice","volume":"118","author":"Steinbicker","year":"2011","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170518091637_GFS584C36","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng1777","article-title":"Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression","volume":"38","author":"Babitt","year":"2006","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20170518091637_GFS584C37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/ng1274","article-title":"Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis","volume":"36","author":"Papanikolaou","year":"2004","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20170518091637_GFS584C38","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00109-008-0313-7","article-title":"A bone morphogenetic protein (BMP)-responsive element in the hepcidin promoter controls HFE2-mediated hepatic hepcidin expression and its response to IL-6 in cultured cells","volume":"86","author":"Verga Falzacappa","year":"2008","journal-title":"J Mol Med"},{"key":"key\n\t\t\t\t20170518091637_GFS584C39","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1172\/JCI31342","article-title":"Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance","volume":"117","author":"Babitt","year":"2007","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170518091637_GFS584C40","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1182\/blood-2010-10-313064","article-title":"Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation","volume":"117","author":"Steinbicker","year":"2011","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170518091637_GFS584C41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nchembio.2007.54","article-title":"Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism","volume":"4","author":"Yu","year":"2008","journal-title":"Nat Chem Biol"},{"key":"key\n\t\t\t\t20170518091637_GFS584C42","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1182\/blood-2011-03-345066","article-title":"Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats","volume":"118","author":"Theurl","year":"2011","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170518091637_GFS584C43","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1093\/ndt\/gfm900","article-title":"Alteration of mRNA expression of molecules related to iron metabolism in adenine-induced renal failure rats: a possible mechanism of iron deficiency in chronic kidney disease patients on treatment","volume":"23","author":"Hamada","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170518091637_GFS584C44","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000183992","article-title":"Animal model of adenine-induced chronic renal failure in rats","volume":"44","author":"Yokozawa","year":"1986","journal-title":"Nephron"},{"key":"key\n\t\t\t\t20170518091637_GFS584C45","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1016\/j.bmcl.2008.06.052","article-title":"Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors","volume":"18","author":"Cuny","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"key\n\t\t\t\t20170518091637_GFS584C46","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1182\/blood-2011-04-348698","article-title":"Regulation of TMPRSS6 by BMP6 and iron in human cells and mice","volume":"118","author":"Meynard","year":"2011","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170518091637_GFS584C47","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.3324\/haematol.2011.048926","article-title":"Pathways for the regulation of hepcidin expression in anemia of chronic disease and iron deficiency anemia in vivo","volume":"96","author":"Theurl","year":"2011","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t20170518091637_GFS584C48","author":"Rasband"},{"key":"key\n\t\t\t\t20170518091637_GFS584C49","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s101570050015","article-title":"Reversibility of adenine-induced renal failure in rats","volume":"3","author":"Okada","year":"1999","journal-title":"Clin Exp Nephrol"},{"key":"key\n\t\t\t\t20170518091637_GFS584C50","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1939-165X.2001.tb00262.x","article-title":"Evaluation of the erythroid regenerative response in two different models of experimentally induced iron deficiency anemia","volume":"30","author":"Burkhard","year":"2001","journal-title":"Vet Clin Pathol"},{"key":"key\n\t\t\t\t20170518091637_GFS584C51","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1172\/JCI112013","article-title":"Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass","volume":"76","author":"Anderson","year":"1985","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170518091637_GFS584C52","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1073\/pnas.85.16.6142","article-title":"Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass","volume":"85","author":"Garcia","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170518091637_GFS584C53","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02172079","article-title":"Effect of purified recombinant human erythropoietin on anemia in rats with experimental renal failure induced by five-sixth nephrectomy","volume":"2","author":"Kawamura","year":"1990","journal-title":"Biotherapy"},{"key":"key\n\t\t\t\t20170518091637_GFS584C54","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000072913","article-title":"Effects of erythropoietin-gene electrotransfer in rats with adenine-induced renal failure","volume":"23","author":"Ataka","year":"2003","journal-title":"Am J Nephrol"},{"key":"key\n\t\t\t\t20170518091637_GFS584C55","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2009-09-245977","article-title":"Anti-hepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia","volume":"115","author":"Sasu","year":"2010","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170518091637_GFS584C56","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2141.1982.tb01938.x","article-title":"Immunoreactive erythropoietin in serum. I. Evidence for the validity of the assay method and the physiological relevance of estimates","volume":"50","author":"Cotes","year":"1982","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20170518091637_GFS584C57","first-page":"624","article-title":"Radioimmunoassay of erythropoietin: circulating levels in normal and polycythemic human beings","volume":"99","author":"Garcia","year":"1982","journal-title":"J Lab Clin Med"},{"key":"key\n\t\t\t\t20170518091637_GFS584C58","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ki.1984.36","article-title":"Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency","volume":"25","author":"McGonigle","year":"1984","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170518091637_GFS584C59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cmet.2008.06.009","article-title":"Fine tuning of hepcidin expression by positive and negative regulators","volume":"8","author":"Muckenthaler","year":"2008","journal-title":"Cell Metab"},{"key":"key\n\t\t\t\t20170518091637_GFS584C60","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1053\/j.gastro.2010.07.044","article-title":"BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice","volume":"139","author":"Corradini","year":"2010","journal-title":"Gastroenterology"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/28\/7\/1733\/17173673\/gfs584.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T20:45:25Z","timestamp":1562618725000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article-lookup\/doi\/10.1093\/ndt\/gfs584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,22]]},"references-count":60,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,1,22]]},"published-print":{"date-parts":[[2013,7]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfs584","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1,22]]}}}